Welcome to MyStrategist, an online experience like no other in the medical device industry.

MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today.

Subscribe   Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Registration is now open for the 7th annual Innovation Summit Dublin, April 21-23, 2020. Early-bird rate expires December 31st!

Register   Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

OrthoPediatrics’ Case for a Kid-Focused Orthopedic Business

Backed by a deep-pocketed family fund, 12-year-old OrthoPediatrics is successfully building a brand in the largely overlooked niche of pediatric orthopedics. The company’s recent acquisition of Vilex shows its growing confidence, and also underscores the necessity of a “stick-to-the-knitting” strategy in a field that many believe has limited potential.

Subscribe now to read the full analysis

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More
More From MedTech Strategist:

Is There a First-Mover Advantage in Medtech?—Notes from PCR 2016

Presentations at the recent Paris Course on Revascularization caused our Editor-in-Chief to ruminate about the future validity of the “first-mover advantage,” particularly in light of customer consolidation and the equal weight of economics and outcomes in the product selection analysis.

Read Article